Professional Documents
Culture Documents
A. Autoimmune Hepatitis
Two formed of AIH are recognized in childhood depending on the presence of diagnostic
autoantibodies-one associated:
1. antinuclear (ANA) and Smooth muscle antibodies (SMA)
2. Liver-kidney microsomal type 1 (LKM1) antibodies
Pathogenesis
Liver damage in AIH is initiated by CD4 positive T lymphocytes recognizing a self-
antigenic peptide. Once the autoimmune reaction,hepatocytesare destroyed by
direct T-cell cytotoxicity,cytolytic action of cytokines and autoantibody-directed
complement or killer cell mediated lysis.
Epidemiology
Age: 6 months to 16 years peak incidence at 10 years
Gender: Female
Clinical Manifestations
Onset: Ill-defined.
60% with prolonged acute hepatitis.
Insidious with history of progressive increasing fatigue, relapsing
jaundice, anorexia and weight loss.
Diagnosis
Presence of ANA, anti-SMA and anti-LKM-1
Liver biopsy
Treatment
Prednisolone
It is defined as the rapid development of the liver injury with with severe impairment of the
synthetic function with or without hepatic encephalopathy in patient with no preexisting liver disease.
Etiology
During the neonatal period, neonatal hemochromatosis or an abnormal accumulation is the
most frequently recognized cause of the ALF and most common indication for the liver
transplantation.
Hep B infection, enteroviral and echoviral hepatitis.
Drugs: Acetaminophen and idiosyncratic reactions
Metabolic dse.
Autoimmune liver diseases.
Vascular insult
Malignant infiltration
Clinical Manifestations
Diagnosis
Prothrombin time
Suspected when the value even after administration of Vitamin K is either one of the ff:
1. 6 sec. longer thancontrol value
2. >50 sec
3. <25% activity.
An international normalized ration (INR) reported as >1.7 presence of ALF.
Treatment
1. Liver transplant
CIRRHOSIS
Etiology
Biliary atresia
Pathogenesis
Liver fibrosis Distortion of the hepatic vasculature Shunting of the portal and
arterial blood supply directly into hepatic outflow and compromising exchange between hepatic
sinusoids and adjacent liver parenchyma.
Clinical manifestations
Child-pugh score
Parameters 1 2 3
Bilirubin (mg/dl) <2 2-5 >5
Albumin (g-dl) >3.5 2.8-3.5 <2.8
PT 1-4 4-6 >6
Hepatic Absent Stage 1-2 Stage 3-4
encephalopathy
Ascites Absent Mild to moderate Severe
Note: Scores >10 signifies severe liver disease warranting immediate liver transplantation
Diagnosis:
1. Biopsy-Gold standard
2. Ultrasound
3. CT scan
4. MRI
Complications:
1. Portal hypertension
2. Ascites
3. Spontaneous bacterial peritonitis
4. Hepatic encephalopathy
5. Hepatorenal Syndrome
QUESTIONS
1. What are the 2 clinical signs of Cirrhosis under the Child-Pugh-Turcotte (CPT) classification?
-Ascites and encephalopathy